semaglutide efectos secundarios a largo plazo La semaglutida está transformando el manejo de la diabetes y la obesidad, pero también abre nuevas conversaciones en consulta 👁️ Desde visión borrosa hasta cambios en retinopatía, entender sus implicaciones permite orientar Riesgos de Ozempic para bajar

The DCCT study demonstrated that intensive insulin therapy in T1D significantly reduced the risk of DPN by 64% and cardiovascular autonomic neuropathy by 45% compared with conventional treatment, with these benefits persisting for over 13 years after the trial ended [60]

Interestingly, renal urate excretion decrease but intestinal expression of ABCG2 increases, suggesting some sort of remote regulation of intestinal urate transport when renal transport is compromised

Regulatory status may change readers should check MHRA and EMA updates for the latest position

Glucagon receptor agonism introduces a catabolic metabolic component that is unique among current obesity therapeutics